These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37245649)

  • 1. Degradation of neuromuscular junction contributes to muscle weakness but not physical compromise in chronic obstructive pulmonary disease patients taking lipids-lowering medications.
    Qaisar R; Karim A; Muhammad T; Alkahtani SA; Kamli H; Ahmad F
    Respir Med; 2023; 215():107298. PubMed ID: 37245649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACE Inhibitors Improve Skeletal Muscle by Preserving Neuromuscular Junctions in Patients with Alzheimer's Disease.
    Qaisar R; Karim A; Iqbal MS; Alkahtani SA; Ahmad F; Kamli H
    J Alzheimers Dis; 2023; 94(2):641-650. PubMed ID: 37334602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated plasma zonulin and CAF22 are correlated with sarcopenia and functional dependency at various stages of Alzheimer's diseases.
    Karim A; Iqbal MS; Muhammad T; Ahmad F; Qaisar R
    Neurosci Res; 2022 Nov; 184():47-53. PubMed ID: 35940439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multistrain probiotic improves handgrip strength and functional capacity in patients with COPD: A randomized controlled trial.
    Karim A; Muhammad T; Shahid Iqbal M; Qaisar R
    Arch Gerontol Geriatr; 2022; 102():104721. PubMed ID: 35567889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated plasma CAF22 are incompletely restored six months after COVID-19 infection in older men.
    Karim A; Muhammad T; Iqbal MS; Qaisar R
    Exp Gerontol; 2023 Jan; 171():112034. PubMed ID: 36423404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma CAF22 Levels as a Useful Predictor of Muscle Health in Patients with Chronic Obstructive Pulmonary Disease.
    Qaisar R; Karim A; Muhammad T
    Biology (Basel); 2020 Jul; 9(7):. PubMed ID: 32679792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Sarcopenia Using Multiple Biomarkers of Neuromuscular Junction Degeneration in Chronic Obstructive Pulmonary Disease.
    Karim A; Muhammad T; Qaisar R
    J Pers Med; 2021 Sep; 11(9):. PubMed ID: 34575696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal permeability marker zonulin as a predictor of sarcopenia in chronic obstructive pulmonary disease.
    Karim A; Muhammad T; Ustrana S; Qaisar R
    Respir Med; 2021; 189():106662. PubMed ID: 34673346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does hand grip strength decrease in chronic obstructive pulmonary disease exacerbation? A cross-sectional study.
    Turan Z; Özyemişçi Taşkıran Ö; Erden Z; Köktürk N; Kaymak Karataş G
    Turk J Med Sci; 2019 Jun; 49(3):802-808. PubMed ID: 31190519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin protects men but not women with HIV against loss of muscle mass, strength, and physical function: a pilot study.
    Cárdenas JDG; Oliveira VHF; Borsari AL; Marinello PC; Longenecker CT; Deminice R
    Sci Rep; 2023 Mar; 13(1):4693. PubMed ID: 36949103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Sarcopenia Using Biomarkers of the Neuromuscular Junction in Parkinson's Disease.
    Karim A; Iqbal MS; Muhammad T; Qaisar R
    J Mol Neurosci; 2022 Apr; 72(4):820-829. PubMed ID: 35044622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interobserver Reliability of Peripheral Muscle Strength Tests and Short Physical Performance Battery in Patients With Chronic Obstructive Pulmonary Disease: A Prospective Observational Study.
    Medina-Mirapeix F; Bernabeu-Mora R; Llamazares-Herrán E; Sánchez-Martínez MP; García-Vidal JA; Escolar-Reina P
    Arch Phys Med Rehabil; 2016 Nov; 97(11):2002-2005. PubMed ID: 27255806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Biomarkers of Accelerated Sarcopenia in Respiratory Diseases.
    Qaisar R; Karim A; Muhammad T; Shah I
    Biology (Basel); 2020 Oct; 9(10):. PubMed ID: 33023021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoke-induced neuromuscular junction degeneration precedes the fibre type shift and atrophy in chronic obstructive pulmonary disease.
    Kapchinsky S; Vuda M; Miguez K; Elkrief D; de Souza AR; Baglole CJ; Aare S; MacMillan NJ; Baril J; Rozakis P; Sonjak V; Pion C; Aubertin-Leheudre M; Morais JA; Jagoe RT; Bourbeau J; Taivassalo T; Hepple RT
    J Physiol; 2018 Jul; 596(14):2865-2881. PubMed ID: 29663403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic Characteristics of Patients With Chronic Obstructive Pulmonary Disease After Stratification for the Short Physical Performance Battery Summary Score.
    Stoffels AAF; De Brandt J; Meys R; van Hees HWH; Vaes AW; Klijn P; Burtin C; Franssen FME; van den Borst B; Sillen MJH; Wouters EFM; Janssen DJA; Spruit MA;
    Arch Phys Med Rehabil; 2020 Nov; 101(11):1887-1897. PubMed ID: 32497598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin use is associated with reduced mortality in COPD.
    Søyseth V; Brekke PH; Smith P; Omland T
    Eur Respir J; 2007 Feb; 29(2):279-83. PubMed ID: 17050558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin Use and the Risk of Subsequent Hospitalized Exacerbations in COPD Patients with Frequent Exacerbations.
    Lin CM; Yang TM; Yang YH; Tsai YH; Lee CP; Chen PC; Chen WC; Hsieh MJ
    Int J Chron Obstruct Pulmon Dis; 2020; 15():289-299. PubMed ID: 32103928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Handgrip Strength Seems Not to Be Affected by COPD Disease Progression: A Longitudinal Cohort Study.
    Kohlbrenner D; Sievi NA; Roeder M; Thurnheer R; Leuppi JD; Irani S; Frey M; Brutsche M; Brack T; Kohler M; Clarenbach CF
    COPD; 2020 Apr; 17(2):150-155. PubMed ID: 32070141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Handgrip strength is associated with dyspnoea and functional exercise capacity in male patients with stable COPD.
    Wu ZY; Han YX; Niu ME; Chen Y; Zhang XQ; Qian HY
    Int J Tuberc Lung Dis; 2019 Apr; 23(4):428-432. PubMed ID: 31064621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Short Physical Performance Battery is a discriminative tool for identifying patients with COPD at risk of disability.
    Bernabeu-Mora R; Medina-Mirapeix F; Llamazares-Herrán E; García-Guillamón G; Giménez-Giménez LM; Sánchez-Nieto JM
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2619-26. PubMed ID: 26664110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.